Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Martelli

Showing results (351-360 of 549) with videos related to

Pageof 55
Sort By:
Journal of Clinical & Laboratory Immunology|July 1, 1986
The analysis of expanded cells from patients with lymphoproliferative disorders of granular lymphocytes may help to clarify the NK cell differentiationR Zambello, T Chisesi, G De Rossi, et al.
Expert Opinion on Therapeutic Targets|June 13, 2012
Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignanciesAlberto M Martelli, Francesca Chiarini, Camilla Evangelisti, et al.
Leukemia|February 20, 2003
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulationR Bortul, P L Tazzari, A Cappellini, et al.
Leukemia|September 13, 2003
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cellsA M Martelli, P L Tazzari, G Tabellini, et al.
The Journal of Pathology|January 10, 1998
Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomasE Pescarmona, V De Sanctis, A Pistilli, et al.
Leukemia|March 16, 2007
The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretionP L Tazzari, G Tabellini, R Bortul, et al.
Cancer Research|April 9, 2009
Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemiaFrancesca Chiarini, Federica Falà, Pier Luigi Tazzari, et al.
Advances in Enzyme Regulation|January 1, 1990
Nuclear inositol lipids. Relationship between growth factor induced metabolic changes and protein kinase C activityL Cocco, S Capitani, A M Martelli, et al.
Haematologica|November 1, 1989
A phase III comparative trial of m-BACOD vs m-BNCOD in the treatment of stage II-IV diffuse non-Hodgkin's lymphomasC Guglielmi, F Gherlinzoni, S Amadori, et al.
Biological Psychology|September 30, 2021
Neural mechanisms of intimate partner aggressionDavid S Chester, Alexandra M Martelli, Samuel J West, et al.
Pageof 55

Showing results (351-360 of 549) with videos related to

Sort By:
Pageof 55
Journal of Clinical & Laboratory Immunology|July 1, 1986
The analysis of expanded cells from patients with lymphoproliferative disorders of granular lymphocytes may help to clarify the NK cell differentiationR Zambello, T Chisesi, G De Rossi, et al.
Expert Opinion on Therapeutic Targets|June 13, 2012
Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignanciesAlberto M Martelli, Francesca Chiarini, Camilla Evangelisti, et al.
Leukemia|February 20, 2003
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulationR Bortul, P L Tazzari, A Cappellini, et al.
Leukemia|September 13, 2003
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cellsA M Martelli, P L Tazzari, G Tabellini, et al.
The Journal of Pathology|January 10, 1998
Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomasE Pescarmona, V De Sanctis, A Pistilli, et al.
Leukemia|March 16, 2007
The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretionP L Tazzari, G Tabellini, R Bortul, et al.
Cancer Research|April 9, 2009
Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemiaFrancesca Chiarini, Federica Falà, Pier Luigi Tazzari, et al.
Advances in Enzyme Regulation|January 1, 1990
Nuclear inositol lipids. Relationship between growth factor induced metabolic changes and protein kinase C activityL Cocco, S Capitani, A M Martelli, et al.
Haematologica|November 1, 1989
A phase III comparative trial of m-BACOD vs m-BNCOD in the treatment of stage II-IV diffuse non-Hodgkin's lymphomasC Guglielmi, F Gherlinzoni, S Amadori, et al.
Biological Psychology|September 30, 2021
Neural mechanisms of intimate partner aggressionDavid S Chester, Alexandra M Martelli, Samuel J West, et al.
Pageof 55